Fuller & Thaler Asset Management, Inc. Omnicell, Inc Transaction History

Fuller & Thaler Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$84.23 - $117.38 $270,209 - $376,555	3,208 Added 3.03%	109,041 $9.49 Million
Q2 2022 Aug 12, 2022	BUY	$105.64 - $129.11 $228,921 - $279,781	2,167 Added 2.09%	105,833 $12 Million
Q1 2022 May 13, 2022	BUY	$120.68 - $180.51 $200,208 - $299,466	1,659 Added 1.63%	103,666 $13.4 Million
Q4 2021 Feb 09, 2022	SELL	$153.26 - $183.62 $2,758 - $3,305	-18 Reduced 0.02%	102,007 $18.4 Million
Q3 2021 Nov 10, 2021	SELL	$141.84 - $160.88 $501,546 - $568,871	-3,536 Reduced 3.35%	102,025 $15.1 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $151.45 $540,555 - $630,183	-4,161 Reduced 3.79%	105,561 $16 Million
Q1 2021 May 13, 2021	BUY	$117.78 - $143.9 $12.9 Million - $15.8 Million	109,722 New	109,722 $14.3 Million

274

44.3M

224K

35.7K

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.87B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.